Elisa Sensi
Pisa, 56126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series.
Journal: Diagnostics (Basel, Switzerland)
Published: April 29, 2021
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy.
Journal: Frontiers in oncology
Published: May 28, 2019
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation.
Journal: The Journal of molecular diagnostics : JMD
Published: May 17, 2019
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 16, 2018
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 06, 2018
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 07, 2018
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 19, 2017
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months.
Journal: Experimental hematology & oncology
Published: December 10, 2016
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 30, 2016
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2016
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.
Journal: Oncology reports
Published: February 15, 2016
Last Updated: 09/26/2026